Artwork

Content provided by Jodi-Tatiana Charles. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jodi-Tatiana Charles or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 48: Meet CONTINUUS Pharmaceuticals chief business officer, Bayan Teisho Takizawa (MA-USA)

49:28
 
Share
 

Manage episode 290089616 series 2880471
Content provided by Jodi-Tatiana Charles. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jodi-Tatiana Charles or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

CONTINUUS Pharmaceuticals is a spin out from the Novartis-MIT Center for CONTINUUS Manufacturing, an $85 joint research endeavor. We are leveraging a novel manufacturing platform call Integrated Continuous Manufacturing, or ICM. With ICM, we were able to take a 200-day manufacturing process and cut it down to just two days. There were additional benefits in costs, footprint, environmental impact, and quality. https://www.continuuspharma.com
Follow CONTINUUS Pharmaceuticals
https://www.linkedin.com/company/continuus-pharmaceuticals/
https://twitter.com/continuusp
Learn about CONTINUUS Pharmaceuticals
https://www.businesswire.com/news/home/20190905005168/en/CONTINUUS-Pharmaceuticals-Raises-5-Series-Led-Mark
https://www.youtube.com/watch?v=NShPYlvgSt4
https://www.youtube.com/watch?v=zD2-9papmOA
https://www.youtube.com/watch?v=WniRiVZb9Ts

Support the show
  continue reading

201 episodes

Artwork
iconShare
 
Manage episode 290089616 series 2880471
Content provided by Jodi-Tatiana Charles. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jodi-Tatiana Charles or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

CONTINUUS Pharmaceuticals is a spin out from the Novartis-MIT Center for CONTINUUS Manufacturing, an $85 joint research endeavor. We are leveraging a novel manufacturing platform call Integrated Continuous Manufacturing, or ICM. With ICM, we were able to take a 200-day manufacturing process and cut it down to just two days. There were additional benefits in costs, footprint, environmental impact, and quality. https://www.continuuspharma.com
Follow CONTINUUS Pharmaceuticals
https://www.linkedin.com/company/continuus-pharmaceuticals/
https://twitter.com/continuusp
Learn about CONTINUUS Pharmaceuticals
https://www.businesswire.com/news/home/20190905005168/en/CONTINUUS-Pharmaceuticals-Raises-5-Series-Led-Mark
https://www.youtube.com/watch?v=NShPYlvgSt4
https://www.youtube.com/watch?v=zD2-9papmOA
https://www.youtube.com/watch?v=WniRiVZb9Ts

Support the show
  continue reading

201 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide